当前位置: 首页 >> 检索结果
7941. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
作者: Nanshan Chen.;Min Zhou.;Xuan Dong.;Jieming Qu.;Fengyun Gong.;Yang Han.;Yang Qiu.;Jingli Wang.;Ying Liu.;Yuan Wei.;Jia'an Xia.;Ting Yu.;Xinxin Zhang.;Li Zhang.
来源: Lancet. 2020年395卷10223期507-513页
In December, 2019, a pneumonia associated with the 2019 novel coronavirus (2019-nCoV) emerged in Wuhan, China. We aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia.
7942. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
作者: Karen Canfell.;Jane J Kim.;Marc Brisson.;Adam Keane.;Kate T Simms.;Michael Caruana.;Emily A Burger.;Dave Martin.;Diep T N Nguyen.;Élodie Bénard.;Stephen Sy.;Catherine Regan.;Mélanie Drolet.;Guillaume Gingras.;Jean-Francois Laprise.;Julie Torode.;Megan A Smith.;Elena Fidarova.;Dario Trapani.;Freddie Bray.;Andre Ilbawi.;Nathalie Broutet.;Raymond Hutubessy.
来源: Lancet. 2020年395卷10224期591-603页
WHO is developing a global strategy towards eliminating cervical cancer as a public health problem, which proposes an elimination threshold of four cases per 100 000 women and includes 2030 triple-intervention coverage targets for scale-up of human papillomavirus (HPV) vaccination to 90%, twice-lifetime cervical screening to 70%, and treatment of pre-invasive lesions and invasive cancer to 90%. We assessed the impact of achieving the 90-70-90 triple-intervention targets on cervical cancer mortality and deaths averted over the next century. We also assessed the potential for the elimination initiative to support target 3.4 of the UN Sustainable Development Goals (SDGs)-a one-third reduction in premature mortality from non-communicable diseases by 2030.
7943. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
作者: Marc Brisson.;Jane J Kim.;Karen Canfell.;Mélanie Drolet.;Guillaume Gingras.;Emily A Burger.;Dave Martin.;Kate T Simms.;Élodie Bénard.;Marie-Claude Boily.;Stephen Sy.;Catherine Regan.;Adam Keane.;Michael Caruana.;Diep T N Nguyen.;Megan A Smith.;Jean-François Laprise.;Mark Jit.;Michel Alary.;Freddie Bray.;Elena Fidarova.;Fayad Elsheikh.;Paul J N Bloem.;Nathalie Broutet.;Raymond Hutubessy.
来源: Lancet. 2020年395卷10224期575-590页
The WHO Director-General has issued a call for action to eliminate cervical cancer as a public health problem. To help inform global efforts, we modelled potential human papillomavirus (HPV) vaccination and cervical screening scenarios in low-income and lower-middle-income countries (LMICs) to examine the feasibility and timing of elimination at different thresholds, and to estimate the number of cervical cancer cases averted on the path to elimination.
7946. A disclosure form for work submitted to medical journals: a proposal from the International Committee of Medical Journal Editors.
作者: Darren B Taichman.;Joyce Backus.;Christopher Baethge.;Howard Bauchner.;Annette Flanagin.;Fernando Florenzano.;Frank A Frizelle.;Fiona Godlee.;Laragh Gollogly.;Abraham Haileamlak.;Sung-Tae Hong.;Richard Horton.;Astrid James.;Christine Laine.;Pamela W Miller.;Anja Pinborg.;Eric J Rubin.;Peush Sahni.
来源: Lancet. 2022年399卷10330期e15-e16页 7947. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
作者: Chaolin Huang.;Yeming Wang.;Xingwang Li.;Lili Ren.;Jianping Zhao.;Yi Hu.;Li Zhang.;Guohui Fan.;Jiuyang Xu.;Xiaoying Gu.;Zhenshun Cheng.;Ting Yu.;Jiaan Xia.;Yuan Wei.;Wenjuan Wu.;Xuelei Xie.;Wen Yin.;Hui Li.;Min Liu.;Yan Xiao.;Hong Gao.;Li Guo.;Jungang Xie.;Guangfa Wang.;Rongmeng Jiang.;Zhancheng Gao.;Qi Jin.;Jianwei Wang.;Bin Cao.
来源: Lancet. 2020年395卷10223期497-506页
A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients.
7950. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.
作者: Jasper Fuk-Woo Chan.;Shuofeng Yuan.;Kin-Hang Kok.;Kelvin Kai-Wang To.;Hin Chu.;Jin Yang.;Fanfan Xing.;Jieling Liu.;Cyril Chik-Yan Yip.;Rosana Wing-Shan Poon.;Hoi-Wah Tsoi.;Simon Kam-Fai Lo.;Kwok-Hung Chan.;Vincent Kwok-Man Poon.;Wan-Mui Chan.;Jonathan Daniel Ip.;Jian-Piao Cai.;Vincent Chi-Chung Cheng.;Honglin Chen.;Christopher Kim-Ming Hui.;Kwok-Yung Yuen.
来源: Lancet. 2020年395卷10223期514-523页
An ongoing outbreak of pneumonia associated with a novel coronavirus was reported in Wuhan city, Hubei province, China. Affected patients were geographically linked with a local wet market as a potential source. No data on person-to-person or nosocomial transmission have been published to date.
7957. Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.
作者: Andrew Lotery.;Sobha Sivaprasad.;Abby O'Connell.;Rosie A Harris.;Lucy Culliford.;Lucy Ellis.;Angela Cree.;Savita Madhusudhan.;Francine Behar-Cohen.;Usha Chakravarthy.;Tunde Peto.;Chris A Rogers.;Barnaby C Reeves.; .
来源: Lancet. 2020年395卷10220期294-303页
In chronic central serous chorioretinopathy (CSCR), fluid accumulates in the subretinal space. CSCR is a common visually disabling condition that develops in individuals up to 60 years of age, and there is no definitive treatment. Previous research suggests the mineralocorticoid receptor antagonist, eplerenone, is effective for treating CSCR; however, this drug is not licensed for the treatment of patients with CSCR. We aimed to evaluate whether eplerenone was superior to placebo in terms of improving visual acuity in patients with chronic CSCR.
7958. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
作者: Matthew K Hoffman.;Shivaprasad S Goudar.;Bhalachandra S Kodkany.;Mrityunjay Metgud.;Manjunath Somannavar.;Jean Okitawutshu.;Adrien Lokangaka.;Antoinette Tshefu.;Carl L Bose.;Abigail Mwapule.;Musaku Mwenechanya.;Elwyn Chomba.;Waldemar A Carlo.;Javier Chicuy.;Lester Figueroa.;Ana Garces.;Nancy F Krebs.;Saleem Jessani.;Farnaz Zehra.;Sarah Saleem.;Robert L Goldenberg.;Kunal Kurhe.;Prabir Das.;Archana Patel.;Patricia L Hibberd.;Emmah Achieng.;Paul Nyongesa.;Fabian Esamai.;Edward A Liechty.;Norman Goco.;Jennifer Hemingway-Foday.;Janet Moore.;Tracy L Nolen.;Elizabeth M McClure.;Marion Koso-Thomas.;Menachem Miodovnik.;R Silver.;Richard J Derman.; .
来源: Lancet. 2020年395卷10220期285-293页
Preterm birth remains a common cause of neonatal mortality, with a disproportionately high burden in low-income and middle-income countries. Meta-analyses of low-dose aspirin to prevent pre-eclampsia suggest that the incidence of preterm birth might also be decreased, particularly if initiated before 16 weeks of gestation.
|